(Q34856676)

4 August 2017

1 reference

title

A review of measurement of patient preferences for treatment outcomes after prostate cancer (English)

1 reference

4 August 2017

1 reference

1 reference

Deborah P Lubeck

1

1 reference

4 August 2017

Gary D Grossfeld

series ordinal

2

1 reference

4 August 2017

Peter R Carroll

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

60

1 reference

4 August 2017

issue

3 Suppl 1

1 reference

4 August 2017

page(s)

72-7; discussion 77-8

1 reference

4 August 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Measuring health related quality of life in men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Comparison of perspectives on prostate cancer: analyses of survey data.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Sex or survival: trade-offs between quality and quantity of life

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Patient-re ported complications and follow-up treatment after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Patient preferences versus physician perceptions of treatment decisions in cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Methodology for measuring health-state preferences--I: Measurement strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

The "utility" of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Utility approach to measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Assessing the performance of utility techniques in the absence of a gold standard.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

How patients' preferences for risk information influence treatment choice in a case of high risk and high therapeutic uncertainty: asymptomatic localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Assessment of the feasibility and impact of shared decision making in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Prostate cancer patients' utilities for health states: how it looks depends on where you stand.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Assessment of patient preferences among men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

Health Literacy and Shared Decision Making for Prostate Cancer Patients with Low Socioeconomic Status

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901577-7

7 January 2021

10.1016/S0090-4295(02)01577-7

Identifiers

DOI

1 reference

4 August 2017

1 reference